Immunome Inc (NASDAQ: IMNM) on Tuesday, soared 3.61% from the previous trading day, before settling in for the closing price of $12.45. Within the past 52 weeks, IMNM’s price has moved between $6.93 and $30.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 26.27%. With a float of $48.99 million, this company’s outstanding shares have now reached $60.05 million.
Let’s look at the performance matrix of the company that is accounted for 55 employees. In terms of profitability, gross margin is 87.4%, operating margin of -2518.49%, and the pretax margin is -2435.02%.
Immunome Inc (IMNM) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immunome Inc is 18.42%, while institutional ownership is 79.04%. The most recent insider transaction that took place on Sep 19 ’24, was worth 230,224. In this transaction Chief Financial Officer of this company sold 14,380 shares at a rate of $16.01, taking the stock ownership to the 47,476 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 14,380 for $16.01, making the entire transaction worth $230,211.
Immunome Inc (IMNM) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.46 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.16) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.27% per share during the next fiscal year.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Immunome Inc (IMNM) is currently performing well based on its current performance indicators. A quick ratio of 7.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 71.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.69, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.82 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
Immunome Inc (NASDAQ: IMNM) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 13.77%. Additionally, its Average True Range was 0.90.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 31.88%, which indicates a significant increase from 15.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.88% in the past 14 days, which was lower than the 67.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.30, while its 200-day Moving Average is $16.36. Nevertheless, the first resistance level for the watch stands at $13.38 in the near term. At $13.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.34. If the price goes on to break the first support level at $12.43, it is likely to go to the next support level at $11.96. Assuming the price breaks the second support level, the third support level stands at $11.47.
Immunome Inc (NASDAQ: IMNM) Key Stats
Market capitalization of the company is 774.64 million based on 59,969K outstanding shares. Right now, sales total 14,020 K and income totals -106,810 K. The company made 2,360 K in profit during its latest quarter, and -36,120 K in sales during its previous quarter.
